World's Best Scientists 2026 revealed!
Award Badge
Molecular Biology
USA
2026

D-Index & Metrics

Molecular Biology

D-Index
146
Citations
77333
World Ranking
97
National Ranking
61

Kevan M. Shokat publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Kevan M. Shokat sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 496 publications — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Kevan M. Shokat D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Kevan M. Shokat sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 146 D-Index — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Molecular Biology in United States Leader Award
  • 2025 - Research.com Molecular Biology in United States Leader Award
  • 2023 - Research.com Molecular Biology in United States Leader Award
  • 2011 - Fellow of the American Academy of Arts and Sciences
  • 2010 - Member of the National Academy of Medicine (NAM)
  • 2009 - Member of the National Academy of Sciences

Overview

Kevan M. Shokat is affiliated with the University of California, San Francisco in the United States. Their research contributions span various topics within biochemistry, genetics, molecular biology, medicine, immunology, and microbiology.

Their recent publications include:

  • Targeting Ras-, Rho-, and Rab-family GTPases via a conserved cryptic pocket (2024, Cell)
  • IL-13 and IL-17A activate β1 integrin through an NF-kB/Rho kinase/PIP5K1γ pathway to enhance force transmission in airway smooth muscle (2024, Proceedings of the National Academy of Sciences)
  • Abstract PL02-01: Overcoming the undruggable nature of the most common human oncogene, K-Ras (2025, Cancer Research)

Frequent co-authors collaborating with Shokat include Johannes Morstein, Vickie Bowcut, Micah C. Fernando, Yue Yang, and Lawrence Zhu.

Shokat's work has been published in venues such as Cell, Proceedings of the National Academy of Sciences, and Cancer Research.

The scientist's main fields of study are:

  • Biochemistry, Genetics and Molecular Biology
  • Medicine
  • Immunology and Microbiology

Within these fields, subfields of focus include:

  • Molecular Biology
  • Immunology
  • Cell Biology
  • Physiology
  • Pulmonary and Respiratory Medicine

Topics addressed in Shokat's research cover:

  • Protein Kinase Regulation and GTPase Signaling
  • Cellular transport and secretion
  • Cell death mechanisms and regulation
  • Asthma and respiratory diseases
  • IL-33, ST2, and ILC Pathways
  • Immune Response and Inflammation
  • PI3K/AKT/mTOR signaling in cancer

The scientist has received several recognitions including:

  • Fellow of the American Academy of Arts and Sciences in 2011
  • Member of the National Academy of Medicine in 2010
  • Member of the National Academy of Sciences in 2009

Best Publications

  • A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.

    David E. Gordon;Gwendolyn M. Jang;Mehdi Bouhaddou;Jiewei Xu

  • RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF

    Poulikos I. Poulikakos;Chao Zhang;Gideon Bollag;Kevan M. Shokat

  • IRE1 Signaling Affects Cell Fate During the Unfolded Protein Response

    Jonathan H. Lin;Han Li;Douglas Yasumura;Hannah R. Cohen

  • The translational landscape of mTOR signalling steers cancer initiation and metastasis

    Andrew C. Hsieh;Yi Liu;Merritt P. Edlind;Nicholas T. Ingolia

  • Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3.

    Natalia V. Sergina;Megan Rausch;Donghui Wang;Jimmy Blair

  • A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin Signaling

    Zachary A Knight;Beatriz Gonzalez;Morri E Feldman;Eli R Zunder

  • The LuxS family of bacterial autoinducers: biosynthesis of a novel quorum-sensing signal molecule

    Stephan Schauder;Kevan Shokat;Michael G. Surette;Bonnie L. Bassler

  • Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2.

    Morris E Feldman;Beth Apsel;Aino Uotila;Robbie Loewith

  • A chemical switch for inhibitor-sensitive alleles of any protein kinase

    Anthony C. Bishop;Jeffrey A. Ubersax;Dejah T. Petsch;Dina P. Matheos

  • Targets of the cyclin-dependent kinase Cdk1

    Jeffrey A. Ubersax;Erika L. Woodbury;Erika L. Woodbury;Phuong N. Quang;Phuong N. Quang;Maria Paraz;Maria Paraz

  • The Global Phosphorylation Landscape of SARS-CoV-2 Infection.

    Mehdi Bouhaddou;Danish Memon;Bjoern Meyer;Kris M. White

  • Human Catechol-O-Methyltransferase Haplotypes Modulate Protein Expression by Altering mRNA Secondary Structure

    A. G. Nackley;S. A. Shabalina;I. E. Tchivileva;K. Satterfield

  • T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR

    Stephan Sauer;Ludovica Bruno;Arnulf Hertweck;David Finlay

  • The unfolded protein response signals through high-order assembly of Ire1.

    Alexei V. Korennykh;Pascal F. Egea;Andrei A. Korostelev;Janet Finer-Moore

  • Targeting the cancer kinome through polypharmacology.

    Zachary A. Knight;Henry Lin;Kevan M. Shokat

  • Features of Selective Kinase Inhibitors

    Zachary A. Knight;Kevan M. Shokat;Kevan M. Shokat

  • A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma

    Qi-Wen Fan;Zachary A. Knight;David D. Goldenberg;Wei Yu

  • Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.

    David E. Gordon;Joseph Hiatt;Mehdi Bouhaddou;Veronica V. Rezelj

  • Structural bioinformatics-based design of selective, irreversible kinase inhibitors.

    Michael S. Cohen;Chao Zhang;Kevan M. Shokat;Jack Taunton

  • Site-specific installation of methyl-lysine analogues into recombinant histones

    Kevan Shokat;Matthew D. Simon

Frequent Co-Authors

Nevan J. Krogan
Nevan J. Krogan University of California, San Francisco
Alma L. Burlingame
Alma L. Burlingame University of California, San Francisco
Kavita Shah
Kavita Shah Purdue University West Lafayette
Robert P. Fisher
Robert P. Fisher Icahn School of Medicine at Mount Sinai
Peter G. Schultz
Peter G. Schultz Scripps Research Institute
Frank McCormick
Frank McCormick University of California, San Francisco
Andrei Goga
Andrei Goga University of California, San Francisco
Davide Ruggero
Davide Ruggero University of California, San Francisco
Arthur Weiss
Arthur Weiss University of California, San Francisco
Peter Walter
Peter Walter University of California, San Francisco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in expanding beyond molecular biology, there are several online degree options and career pathways that offer both flexibility and specialization. Those looking into healthcare might consider accelerated BSN programs for non nurses, which provide a fast track into nursing even for those without a prior nursing background.

If communication science and helping others is your calling, you may explore asha approved slp programs online—these programs follow industry standards and can launch a rewarding career in speech-language pathology.

For non-SLP majors, online bridge programs non-SLP majors offer a transition into this field without starting from scratch. These flexible programs are ideal for career changers looking to meet educational prerequisites.

Pursuing advanced roles such as psychiatric nurse practitioners is also an option. It’s helpful to review psychiatric nurse practitioner salary data to understand earning potential by state.

Each of these pathways can complement a background in molecular biology, leading to diverse and in-demand careers in science and healthcare.

Best Scientists Citing Kevan M. Shokat

Trending Scientists

Recently Published Articles